Garlic revisited: Antimicrobial activity of allicin-containing garlic extracts against Burkholderia cepacia complex

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Wallock Richards, Daynea ^b   Doherty, Catherine J ^a   Doherty, Lynsey ^a   Clarke, David J ^b   Place, Marc ^b   Govan, John R W ^a   Campopiano, Dominic J ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLICIN; CYSTEINE; GARLIC EXTRACT; PEROXIREDOXIN; ANTIINFECTIVE AGENT; PLANT EXTRACT; SULFINIC ACID DERIVATIVE; WATER;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA COMPLEX; CATALYSIS; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; QUANTITATIVE ASSAY; CHEMISTRY; DRUG EFFECTS; GARLIC;

ALLIUM SATIVUM; BACTERIA (MICROORGANISMS); BURKHOLDERIA CEPACIA COMPLEX;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA COMPLEX; GARLIC; PLANT EXTRACTS; SULFINIC ACIDS; WATER;

EID: 84919338477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112726     Document Type: Article

References (47)

1. Block E (2010) Garlic and Other Alliums: The Lore and the Science. Cambridge, UK: The Royal Society of Chemistry.
2. Cavallito C, Bailey J (1944) Allicin, the Antibacterial Principle of Allium sativum: Isolation, Physical Properties and Antibacterial Action. Journal of American Chemical Society 66: 1950-1951.
3. Cavallito C, Buck J, Suter CM (1944) Allicin, the Antibacterial Principle of Allium sativum: Determination of the Chemical Structure. Journal of American Chemical Society 66: 1952-1954.
4. Cavillito C, Bailey J, Buck J (1945) The Antibacterial Principle of Allium sativum: Its Precursor and Essential Oil of Garlic. Journal of American Chemical Society 67: 1032-1033.
5. Small L, Bailey J, Cavallito C (1947) Alkyl Thiosulfinates. Journal of American Chemical Society 69: 1710-1713.
6. Fujisawa H, Suma K, Origuchi K, Kumagai H, Seki T (2008) Biological and chemical stability of garlic-derived allicin. Journal of Agriculture and Food Chemistry 56: 4229-4235.
7. Lawson L, Wang ZJ (2001) Low Allicin Release from Garlic Supplements: a Major problem Due to the Sensitivities of Allinase Activity. Journal of Agriculture and Food Chemistry 49: 2592-2599.
8. Kyung KH (2012) Antimicrobial properties of allium species. Curr Opin Biotechnol 23: 142-147.
9. Waag T, Gelhaus C, Rath J, Stich A, Leippe M, et al. (2010) Allicin and derivatives are cysteine protease inhibitors with parasitic activity. Bioorganic and Medicinal Chemistry letters 20: 5541-5543.
10. Shimon LJ, Rabinkov A, Shin I, Miron T, Mirelman D, et al. (2007) Two structures of alliinase from Alliium sativum L.: apo form and ternary complex with aminoacrylate reaction intermediate covalently bound to the PLP cofactor. J Mol Biol 366: 611-625.
11. Feldberg R, Chang S, Kotik A, Nadler M, Neuwirth Z (1988) In vitro mechanism of inhibition of bacterial cell growth by allicin. Antimicrobial Agents and Chemotherapy 32: 1763-1768.
12. Fujisawa H, Watanabe K, Suma K, Origuchi K, Matsufuji H (2009) Antimicrobial Potential of Garlic-Derived Allicin and Its Cancellation by Sulfydryl Compounds. Bioscience Biotechnology Biochemistry 73: 1948-1955.
13. Focke M, Feld A, Lichtenthaler H (1990) Allicin, a naturally occuring antibiotic from garlic, specifically inhibits acetyl-CoA synthase. FEBS Letters 261: 106-108.
14. Borlinghaus J, Albrecht F, Gruhlke MC, Nwachukwu ID, Slusarenko AJ (2014) Allicin: Chemistry and Biological Properties. Molecules 19: 12591-12618.
15. Naganawa R, Iwata N, Ishikawa K, Fukuda H, Fujino T, et al. (1996) Inhibition of Microbial Growth by Ajoene, a Sulfur-Containing Compound Derived from Garlic. Applied and Envirnmental Microbiology 62: 4238-4242.
16. Smyth A, Cifelli P, Ortori C, Righetti K, Lewis S, et al. (2010) Garlic as an Inhibitor of Pseudomonas aeruginosa Pediatric Pulmonology 45: 356-362.
17. Jakobsen T, Gennip MV, Phipps R, Shanmugham M, Christensen L, et al. (2012) Ajoene, a sulfurrich molecule from garlic, inhibits genes controlled by quorum. Antimicrob Agents Chemother 56: 2314-2325.
18. Coenye T, Vandamme P, Govan J, Lipauma J (2001) Taxanomy and Indentification of the Burkholderia cepacia complex. Journal of Clinical Microbiology 39: 3427-3436.
19. Holmes A, Govan J, Goldstein R (1998) Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health. Emerging Infectious Diseases 4.
20. Sullivan LA, Mahenthiralingam E (2005) Biotechnological potential within the genus Burkholderia. Letters in Applied Microbiology 41: 8-11.
21. Burkholder W (1950) Sour skin, a bacterial rot of onion bulbs. Phytopathology 40: 115-117.
22. Govan J, Brown A, Jones A (2007) Evolving epidemiology of pseudomonas aeroginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiology 2: 153-164.
23. Greenberg D, Goldberg J, Stock F, Murray P, Holland S, et al. (2009) Recurrent Burkholderia infection in patients with chronic granulomatous disease. Clin Infect Dis 48: 1577-1579.
24. LiPuma J (2010) The changing microbial epidemiology in cystic fibrosis. Clinical Microbiology Reviews 23: 299-323.
25. Nzula S, Vandamme P, Govan J (2002) Influence of taxonomic status on the in vitro antimicrobial suseptibility of the Burkholderia cepacia complex Journal of Antimicrobial Chemotherapy 50: 265-269.
26. Grimwood K, Kidd TJ, Tweed M (2009) Successful treatment of cepacia syndrome. J Cyst Fibros. Netherlands. pp. 291-293.
27. Gilchrist FJ, Webb AK, Bright-Thomas RJ, Jones AM (2012) Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids. J Cyst Fibros 11: 458-460.
28. Horsley A, Webb K, Bright-Thomas R, Govan J, Jones A (2011) Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy? Front Cell Infect Microbiol 1: 18.
29. Horsley A, Jones AM (2012) Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Cochrane Database Syst Rev 10: Cd009529.
30. Tullis DE, Burns JL, Retsch-Bogart GZ, Bresnik M, Henig NR, et al. (2014) Inhaled aztreonam for chronic Burkholderia infection in cystic fibrosis: a placebo-controlled trial. J Cyst Fibros 13: 296-305.
31. Balfour-Lynn IM (2014) At last, Burkholderia spp. is one of the inclusion criteria-a negative (but published) randomised controlled trial. J Cyst Fibros 13: 241-242.
32. Fischbach M, Walsh C (2009) Antibiotics for Emerging Pathogens. Science 325: 1089-1093.
33. Li J, Vederas J (2009) Drug Discovery and natural products. Science 325: 161-165.
34. Mahenthiralingam E, Coenye T, Chung J, Speert D, Govan J, et al. (2000) Diagnostically and experimentally useful panel of strains from the Burkholderia. J Clin Microbiol 38: 910-913.
35. NCCLS (1997) Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard M2-M7. Wayne, PA, USA: National Committee for Clinical Laboratory Standards. pp. 1-182.
36. Clarke DJ, Ortega XP, Mackay CL, Valvano MA, Govan JR, et al. (2010) Subdivision of the bacterioferritin comigratory protein family of bacterial peroxiredoxins based on catalytic activity. Biochemistry 49: 1319-1330.
37. Miron T, Listowsky I, Wilchek M (2010) Reaction mechanisms of allicin and allyl-mixed disulfides with proteins and small thiol molecules. Eur J Med Chem 45: 1912-1918.
38. Taylor K, McCullough B, Clarke D, Langley R, Pechenick T, et al. (2007) Covalent dimer species of beta-defensin Defr1 display potent antimicrobial. Antimicrob Agents Chemother 51: 1719-1724.
39. Loutet SA, Valvano MA (2011) Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia. Front Cell Infect Microbiol 1: 6.
40. Waters V, Ratjen F (2006) Multidrug-resistant organisms in cystic fibrosis: management and. Expert Rev Anti Infect Ther 4: 807-819.
41. Schwan W, Dunek C, Gebhardt M, Engelbrecht K, Klett T, et al. (2010) Screening a mushroom extract library for activity against Acinetobacter baumannii. Ann Clin Microbiol Antimicrob 9.
42. Mahenthiralingam E, Song L, Sass A, White J, Wilmot C, et al. (2011) Enacyloxins are products of an unusual hybrid modular polyketide synthase encoded by a cryptic Burkholderia ambifaria Genomic Island. Chem Biol 18: 665-677.
43. Mil-Homens D, Bernardes N, Fialho A (2012) The antibacterial properties of docosahexaenoic omega-3 fatty acid against the. FEMS Microbiol Lett 328: 61-69.
44. Papaleo MC, Fondi M, Maida I, Perrin E, Lo Giudice A, et al. (2012) Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria. Biotechnol Adv 30: 272-293.
45. Ashry N, Gameil N, Suddek G (2013) Modulation of cyclophosphamide-induced early lung injury by allicin. Pharm Biol 51: 806-811.
46. Banerjee S, Maulik S (2002) Effect of garlic on cardiovascular disorders: a review. Nutr J 2002 1: 4-18.
47. Zhang L, Wang E, Chen F, Yan H, Yuan Y (2013) Potential protective effects of oral administration of allicin on acrylamide-induced toxicity in male mice. Food Funct 4: 1229-1236.